Inhalable Spray-Freeze-Dried Powder with L-Leucine that Delivers Particles Independent of Inspiratory Flow Pattern and Inhalation Device.

about

Influence of physical properties of carrier on the performance of dry powder inhalers A model to integrate patient preferences into delivery systems: the importance of end-user input into pulmonary delivery.

P2860

Q26740570-72539DDC-0641-4309-8526-2B7C0F781072 Q45297182-5907EB6B-5088-4D32-A893-6B57281AA975

P2860

Inhalable Spray-Freeze-Dried Powder with L-Leucine that Delivers Particles Independent of Inspiratory Flow Pattern and Inhalation Device.

Item

http://www.wikidata.org/entity/Q35862967

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Inhalable Spray-Freeze-Dried P ...... Pattern and Inhalation Device.

@ast

Inhalable Spray-Freeze-Dried P ...... Pattern and Inhalation Device.

@en

type

Item

label

Inhalable Spray-Freeze-Dried P ...... Pattern and Inhalation Device.

@ast

Inhalable Spray-Freeze-Dried P ...... Pattern and Inhalation Device.

@en

prefLabel

Inhalable Spray-Freeze-Dried P ...... Pattern and Inhalation Device.

@ast

Inhalable Spray-Freeze-Dried P ...... Pattern and Inhalation Device.

@en

P1476

Inhalable Spray-Freeze-Dried P ...... Pattern and Inhalation Device.

@en

P2093

Daiki Hira

http://www.w3.org/2001/XMLSchema#string

Haruyoshi Kojima

http://www.w3.org/2001/XMLSchema#string

Hiroko Otake

http://www.w3.org/2001/XMLSchema#string

Hirozazu Okamoto

http://www.w3.org/2001/XMLSchema#string

Tomoyuki Okuda

http://www.w3.org/2001/XMLSchema#string

Yasuhiro Shimada

http://www.w3.org/2001/XMLSchema#string

P2860

The use of amino acids to enhance the aerosolisation of spray-dried powders for pulmonary gene therapy.

Adhesion forces in interactive mixtures for dry powder inhalers--evaluation of a new measuring method.

Lactose composite carriers for respiratory delivery.

Co-spray-dried mannitol-ciprofloxacin dry powder inhaler formulation for cystic fibrosis and chronic obstructive pulmonary disease.

Inspiratory flows through dry powder inhaler in chronic obstructive pulmonary disease: age and gender rather than severity matters.

Agglomerate behaviour of fluticasone propionate within dry powder inhaler formulations.

Evolution of dry powder inhaler design, formulation, and performance.

Inhalation therapy: technological milestones in asthma treatment.

Preparation and in vitro aerosol performance of spray-dried Shuang-Huang-Lian corrugated particles in carrier-based dry powder inhalers.

Pure insulin nanoparticle agglomerates for pulmonary delivery.

P304

922-931

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11095-015-1838-4

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-12-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26643921

http://www.w3.org/2001/XMLSchema#string

Inhalable Spray-Freeze-Dried Powder with L-Leucine that Delivers Particles Independent of Inspiratory Flow Pattern and Inhalation Device.

about

P2860

P2860

Inhalable Spray-Freeze-Dried Powder with L-Leucine that Delivers Particles Independent of Inspiratory Flow Pattern and Inhalation Device.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698